OGN

NEUTRALM&A

Organon & Co.

2026-08-18

Price

$13.68

-0.15%

This is the 2026-08-18 snapshot — the signals and analysis for OGN as of this single trading day.

View full OGN research hub →

Score10.5Priority

Signals6/8 DNA1/13 Act · 1/4 Risk

SentimentNEUTRALScore: 7

Volume0.9xvs 20d avg

Analysis

Organon's (OGN) price action and technical signals are entirely driven by its pending all-cash acquisition by Sun Pharma for $14.00 per share, announced in April 2026. The exceptionally low realized volatility (3.2%) and 'Quiet Storm' technicals reflect classic merger arbitrage behavior as the stock anchors to the deal price. Furthermore, the current RISK_ON macro regime and ultra-tight credit spreads provide a highly supportive environment for M&A financing, reinforcing institutional confidence that the deal will close successfully by early 2027.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACKBARGAIN HUNTERWEAK FINISH

Key Takeaways

M&A Arbitrage Anchor: OGN's price is structurally pinned near the $14.00 acquisition price set by Sun Pharma, completely overriding organic market beta [1.1.1].
Technical Validation: The 'Quiet Storm' and 'Perfect Stack' signals are artifacts of a post-announcement holding pattern, rather than a traditional organic breakout.
Favorable Macro Backdrop: Tight credit spreads (0.81%) in the current RISK_ON regime minimize financing risks, supporting a high probability of deal completion.

← Back to 2026-08-18 View Full OGN History →Yahoo Finance &nearr;